Search Results

Cumulative effect of obesity phenotypes on body weight and body mass index.

• Authors : Ghusn W; Precision Medicine for Obesity Program, Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.; Cifuentes L

Subjects: Body Mass Index* ; Obesity*/Obesity*/Obesity*/physiopathology ; Obesity*/Obesity*/Obesity*/psychology

• Source: International journal of obesity (2005) [Int J Obes (Lond)] 2024 Jun; Vol. 48 (6), pp. 884-890. Date of Electronic Publication: 2024 Feb 28.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101256108 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

The association between previous use of anti-obesity medication and semaglutide weight loss outcomes.

• Authors : Ghusn W; Precision Medicine for Obesity Program, Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.; Fansa S

Subjects: Weight Loss*/Weight Loss*/Weight Loss*/drug effects ; Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/therapeutic use ; Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/adverse effects

• Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Jun; Vol. 26 (6), pp. 2167-2175. Date of Electronic Publication: 2024 Mar 12.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Low Incidence of Pulmonary Aspiration During Upper Endoscopy in Patients Prescribed a Glucagon-Like Peptide 1 Receptor Agonist.

• Authors : Anazco D; Precision Medicine for Obesity Program, Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.; Fansa S

Subjects: Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/agonists ; Respiratory Aspiration*; Humans

• Source: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2024 Jun; Vol. 22 (6), pp. Publisher: W.B. Saunders for the American Gastroenterological Association Country of Publication: United States NLM ID: 101160775 Publication Model:

Record details

Unraveling the Variability of Human Satiation: Implications for Precision Obesity Management.

• Authors : Acosta A; Cifuentes L; Anazco D

• Source: Research square [Res Sq] 2024 May 23. Date of Electronic Publication: 2024 May 23.Country of Publication: United States NLM ID: 101768035 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: Res Sq Subsets: PubMed not

Record details

Weight loss outcomes with semaglutide based on diabetes severity using the individualized metabolic surgery score.

• Authors : Ghusn W; Precision Medicine for Obesity Program, Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.; Anazco D

• Source: EClinicalMedicine [EClinicalMedicine] 2024 May 07; Vol. 72, pp. 102625. Date of Electronic Publication: 2024 May 07 (Print Publication: 2024).Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370

Record details

Weight loss and cardiovascular disease risk outcomes of semaglutide: a one-year multicentered study.

• Authors : Ghusn W; Precision Medicine for Obesity Program, Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.; Fansa S

Subjects: Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/therapeutic use ; Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/administration & dosage ; Weight Loss*/Weight Loss*/Weight Loss*/drug effects

• Source: International journal of obesity (2005) [Int J Obes (Lond)] 2024 May; Vol. 48 (5), pp. 662-667. Date of Electronic Publication: 2024 Feb 01.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101256108 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Weight loss response to semaglutide in postmenopausal women with and without hormone therapy use.

• Authors : Hurtado MD; Tama E; Fansa S

Subjects: Overweight* ; Cardiovascular Diseases*; Female

• Source: Menopause (New York, N.Y.) [Menopause] 2024 Apr 01; Vol. 31 (4), pp. 266-274. Date of Electronic Publication: 2024 Mar 05.Publisher: Lippincott-Raven Publishers Country of Publication: United States NLM ID: 9433353 Publication Model: Print-Electronic Cited Medium: Internet

Record details

The melanocortin-4 receptor pathway and the emergence of precision medicine in obesity management.

• Authors : Fansa S; Precision Medicine for Obesity Program, Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.; Acosta A

Subjects: Obesity Management*; Humans ; Receptor, Melanocortin, Type 4/Receptor, Melanocortin, Type 4/Receptor, Melanocortin, Type 4/genetics

• Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Apr; Vol. 26 Suppl 2, pp. 46-63. Date of Electronic Publication: 2024 Mar 19.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Type 2 Diabetes Remission in Patients with Heterozygous Variants in the Leptin-Melanocortin Pathway after Roux-en-Y Gastric Bypass: A Matched Case-Control Study.

• Authors : Anazco D; Precision Medicine for Obesity Program, Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, 200 First St. S.W., Rochester, MN, 55902, USA.; Ghusn W

Subjects: Gastric Bypass* ; Obesity, Morbid*/Obesity, Morbid*/Obesity, Morbid*/surgery ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/genetics

• Source: Obesity surgery [Obes Surg] 2023 Nov; Vol. 33 (11), pp. 3502-3509. Date of Electronic Publication: 2023 Oct 06.Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 9106714 Publication Model: Print-Electronic Cited Medium:

Record details

Efficacy of Antiobesity Medications in Patients With Celiac Disease on a Gluten-free Diet: A Retrospective Matched Cohort Study.

• Authors : Anazco D; Precision Medicine for Obesity Program, Division of Gastroenterology and Hepatology, Department of Medicine.; Fansa S

• Source: Journal of clinical gastroenterology [J Clin Gastroenterol] 2023 Sep 28. Date of Electronic Publication: 2023 Sep 28.Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 7910017 Publication Model: Print-Electronic Cited Medium: Internet

Record details